Analyst Consensus
- Current Price
- 88.41 $
- Target (Low)
- 92.00 $
- Target (Mean)
- 116.54 $
- Target (High)
- 135.00 $
- Recommendation
- Buy
- Number of Analysts
- 24
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 16 |
|---|
| Hold | 7 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 13.9%
- Operating Margin
- 13.5%
- Gross Margin
- 56.5%
- Return on Equity (ROE)
- 12.3%
- Return on Assets (ROA)
- 5.6%
- Revenue Growth
- 7.8%
- Earnings Growth
- -19.7%
- Debt/Equity
- 64.77
- Current Ratio
- 1.39
- Beta
- 0.62
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Apr 27, 2026 | BTIG | Buy → Buy |
| Apr 20, 2026 | Barclays | Overweight → Overweight |
| Apr 17, 2026 | Piper Sandler | Overweight → Overweight |
| Apr 17, 2026 | Oppenheimer | Outperform → Outperform |
| Apr 17, 2026 | RBC Capital | Outperform → Outperform |
| Apr 17, 2026 | Benchmark | Buy → Buy |